{"count": 8, "results": [{"_id": "37106473", "pmid": 37106473, "title": "Association of poor sleep and HbA1c in metformin-treated patients with type 2 diabetes: Findings from the UK Biobank cohort study.", "journal": "J Sleep Res", "authors": ["Xue P", "Tan X", "Benedict C"], "date": "2023-04-27T00:00:00Z", "doi": "10.1111/jsr.13917", "meta_date_publication": "2023 Apr 27", "meta_volume": "", "meta_issue": "", "meta_pages": "e13917", "score": 50252.99, "text_hl": "Association of @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@poor sleep@@@ and HbA1c in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@: Findings from the UK Biobank cohort study.", "citations": {"NLM": "Xue P, Tan X, Benedict C. Association of poor sleep and HbA1c in metformin-treated patients with type 2 diabetes: Findings from the UK Biobank cohort study. J Sleep Res. 2023 Apr 27;():e13917. PMID: 37106473", "BibTeX": "@article{37106473, title={Association of poor sleep and HbA1c in metformin-treated patients with type 2 diabetes: Findings from the UK Biobank cohort study.}, author={Xue P and Tan X and Benedict C}, journal={J Sleep Res}, pages={e13917}}"}}, {"_id": "37829735", "pmid": 37829735, "pmcid": "PMC10565813", "title": "Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment", "journal": "Front Nutr", "authors": ["Bruno E", "Mulè A", "Galasso L", "Castelli L", "Baldassari I", "Oliverio A", "Venturelli E", "Berrino F", "Montaruli A", "Roveda E", "Pasanisi P"], "date": "2023-09-27T00:00:00Z", "doi": "10.3389/fnut.2023.1240762", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1240762", "score": 50252.02, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@GENE_SLTM @GENE_79811 @@@MET@@@), an @GENE_INS @GENE_3630 @@@insulin@@@ sensitizer drug, is effective in regressing @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MS@@@ and has been recently studied as an adjuvant agent for managing @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disorders@@@. ", "citations": {"NLM": "Bruno E, Mulè A, Galasso L, Castelli L, Baldassari I, Oliverio A, Venturelli E, Berrino F, Montaruli A, Roveda E, Pasanisi P. Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment Front Nutr. 2023;10():1240762. PMID: 37829735", "BibTeX": "@article{37829735, title={Sleep behavior and daily activity levels in people with metabolic syndrome: effect of 1 year of metformin treatment}, author={Bruno E and Mulè A and Galasso L and Castelli L and Baldassari I and Oliverio A and Venturelli E and Berrino F and Montaruli A and Roveda E and Pasanisi P}, journal={Front Nutr}, volume={10}, pages={1240762}}"}}, {"_id": "34161489", "pmid": 34161489, "title": "Hyperglycemia in pregnancy: sleep alterations, comorbidities and pharmacotherapy.", "journal": "Rev Assoc Med Bras (1992)", "authors": ["Façanha C", "Bruin V", "Bruin P", "Façanha A", "Rocha HC", "Araujo M", "Forti A", "Macêdo R"], "date": "2021-01-01T00:00:00Z", "doi": "10.1590/1806-9282.67.01.20200216", "meta_date_publication": "2021 Jan", "meta_volume": "67", "meta_issue": "1", "meta_pages": "45-51", "score": 50248.773, "text_hl": "Interestingly, only in @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@gestational diabetes mellitus@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy and higher parity were associated with @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@poor sleep quality@@@.", "citations": {"NLM": "Façanha C, Bruin V, Bruin P, Façanha A, Rocha HC, Araujo M, Forti A, Macêdo R. Hyperglycemia in pregnancy: sleep alterations, comorbidities and pharmacotherapy. Rev Assoc Med Bras (1992). 2021 Jan;67(1):45-51. PMID: 34161489", "BibTeX": "@article{34161489, title={Hyperglycemia in pregnancy: sleep alterations, comorbidities and pharmacotherapy.}, author={Façanha C and Bruin V and Bruin P and Façanha A and Rocha HC and Araujo M and Forti A and Macêdo R}, journal={Rev Assoc Med Bras (1992)}, volume={67}, number={1}, pages={45-51}}"}}, {"_id": "34211432", "pmid": 34211432, "pmcid": "PMC8241224", "title": "Novel Insights Into Monogenic Obesity Syndrome Due to INPP5E Gene Variant: A Case Report of a Female Patient", "journal": "Front Endocrinol (Lausanne)", "authors": ["Drole Torkar A", "Avbelj Stefanija M", "Bertok S", "Trebušak Podkrajšek K", "Debeljak M", "Stirn Kranjc B", "Battelino T", "Kotnik P"], "date": "2021-06-15T00:00:00Z", "doi": "10.3389/fendo.2021.581134", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "581134", "score": 50237.176, "text_hl": "The @SPECIES_9606 @@@patient@@@ is managed by regular nutritional advice, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, antihypertensive medication, and non-invasive respiratory support during @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep@@@. ", "citations": {"NLM": "Drole Torkar A, Avbelj Stefanija M, Bertok S, Trebušak Podkrajšek K, Debeljak M, Stirn Kranjc B, Battelino T, Kotnik P. Novel Insights Into Monogenic Obesity Syndrome Due to INPP5E Gene Variant: A Case Report of a Female Patient Front Endocrinol (Lausanne). 2021;12():581134. PMID: 34211432", "BibTeX": "@article{34211432, title={Novel Insights Into Monogenic Obesity Syndrome Due to INPP5E Gene Variant: A Case Report of a Female Patient}, author={Drole Torkar A and Avbelj Stefanija M and Bertok S and Trebušak Podkrajšek K and Debeljak M and Stirn Kranjc B and Battelino T and Kotnik P}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={581134}}"}}, {"_id": "22701848", "pmid": 22701848, "pmcid": "PMC3354927", "title": "Metformin and sleep disorders", "journal": "Indian J Endocrinol Metab", "authors": ["Wiwanitkit S", "Wiwanitkit V"], "date": "2012-03-01T00:00:00Z", "doi": "10.4103/2230-8210.94262", "meta_date_publication": "2012 Mar", "meta_volume": "16 Suppl 1", "meta_issue": "Suppl1", "meta_pages": "S63-4", "score": 50084.58, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disorders@@@", "citations": {"NLM": "Wiwanitkit S, Wiwanitkit V. Metformin and sleep disorders Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1(Suppl1):S63-4. PMID: 22701848", "BibTeX": "@article{22701848, title={Metformin and sleep disorders}, author={Wiwanitkit S and Wiwanitkit V}, journal={Indian J Endocrinol Metab}, volume={16 Suppl 1}, number={Suppl1}, pages={S63-4}}"}}, {"_id": "25256878", "pmid": 25256878, "title": "Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome.", "journal": "J Pediatr Adolesc Gynecol", "authors": ["El-Sharkawy AA", "Abdelmotaleb GS", "Aly MK", "Kabel AM"], "date": "2014-12-01T00:00:00Z", "doi": "10.1016/j.jpag.2014.01.004", "meta_date_publication": "2014 Dec", "meta_volume": "27", "meta_issue": "6", "meta_pages": "347-52", "score": 50063.9, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disorders@@@ in adolescent girls with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian syndrome@@@.", "citations": {"NLM": "El-Sharkawy AA, Abdelmotaleb GS, Aly MK, Kabel AM. Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2014 Dec;27(6):347-52. PMID: 25256878", "BibTeX": "@article{25256878, title={Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome.}, author={El-Sharkawy AA and Abdelmotaleb GS and Aly MK and Kabel AM}, journal={J Pediatr Adolesc Gynecol}, volume={27}, number={6}, pages={347-52}}"}}, {"_id": "24236897", "pmid": 24236897, "title": "The relationship between metformin therapy and sleep quantity and quality in patients with Type 2 diabetes referred for potential sleep disorders.", "journal": "Diabet Med", "authors": ["Kajbaf F", "Fendri S", "Basille-Fantinato A", "Diouf M", "Rose D", "Jounieaux V", "Lalau JD"], "date": "2014-05-01T00:00:00Z", "doi": "10.1111/dme.12362", "meta_date_publication": "2014 May", "meta_volume": "31", "meta_issue": "5", "meta_pages": "577-80", "score": 50056.64, "text_hl": "The relationship between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy and sleep quantity and quality in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 diabetes@@@ referred for potential @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disorders@@@.", "citations": {"NLM": "Kajbaf F, Fendri S, Basille-Fantinato A, Diouf M, Rose D, Jounieaux V, Lalau JD. The relationship between metformin therapy and sleep quantity and quality in patients with Type 2 diabetes referred for potential sleep disorders. Diabet Med. 2014 May;31(5):577-80. PMID: 24236897", "BibTeX": "@article{24236897, title={The relationship between metformin therapy and sleep quantity and quality in patients with Type 2 diabetes referred for potential sleep disorders.}, author={Kajbaf F and Fendri S and Basille-Fantinato A and Diouf M and Rose D and Jounieaux V and Lalau JD}, journal={Diabet Med}, volume={31}, number={5}, pages={577-80}}"}}, {"_id": "26132721", "pmid": 26132721, "title": "AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.", "journal": "Antioxid Redox Signal", "authors": ["Bullón P", "Alcocer-Gómez E", "Carrión AM", "Marín-Aguilar F", "Garrido-Maraver J", "Román-Malo L", "Ruiz-Cabello J", "Culic O", "Ryffel B", "Apetoh L", "Ghiringhelli F", "Battino M", "Sánchez-Alcazar JA", "Cordero MD"], "date": "2016-01-20T00:00:00Z", "doi": "10.1089/ars.2014.6120", "meta_date_publication": "2016 Jan 20", "meta_volume": "24", "meta_issue": "3", "meta_pages": "157-70", "score": 50030.46, "text_hl": "Deficient @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activation and overactivation of @GENE_DFNA34 @GENE_114548 @@@NLRP3@@@ inflammasome axis were also observed in blood cells from @SPECIES_9606 @@@patients@@@ with @DISEASE_Fibromyalgia @DISEASE_MESH:D005356 @@@fibromyalgia@@@ (@DISEASE_Fibromyalgia @DISEASE_MESH:D005356 @@@FM@@@), a prevalent @SPECIES_9606 @@@human@@@ @DISEASE_Chronic_Pain @DISEASE_MESH:D059350 @@@chronic pain disease@@@. In addition, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment (200 mg/daily), which increased @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activation, restored all biochemical alterations examined by us in blood cells and significantly improved clinical symptoms, such as, @DISEASE_Pain @DISEASE_MESH:D010146 @@@pain@@@, @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@, @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@disturbed sleep@@@, and tender @DISEASE_Belonephobia @DISEASE_MESH:C000719195 @@@points@@@, in @SPECIES_9606 @@@patients@@@ with @DISEASE_Fibromyalgia @DISEASE_MESH:D005356 @@@FM@@@. ", "citations": {"NLM": "Bullón P, Alcocer-Gómez E, Carrión AM, Marín-Aguilar F, Garrido-Maraver J, Román-Malo L, Ruiz-Cabello J, Culic O, Ryffel B, Apetoh L, Ghiringhelli F, Battino M, Sánchez-Alcazar JA, Cordero MD. AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome. Antioxid Redox Signal. 2016 Jan 20;24(3):157-70. PMID: 26132721", "BibTeX": "@article{26132721, title={AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.}, author={Bullón P and Alcocer-Gómez E and Carrión AM and Marín-Aguilar F and Garrido-Maraver J and Román-Malo L and Ruiz-Cabello J and Culic O and Ryffel B and Apetoh L and Ghiringhelli F and Battino M and Sánchez-Alcazar JA and Cordero MD}, journal={Antioxid Redox Signal}, volume={24}, number={3}, pages={157-70}}"}}]}